[go: up one dir, main page]

MX2022008016A - Compuesto antagonista de pd-l1. - Google Patents

Compuesto antagonista de pd-l1.

Info

Publication number
MX2022008016A
MX2022008016A MX2022008016A MX2022008016A MX2022008016A MX 2022008016 A MX2022008016 A MX 2022008016A MX 2022008016 A MX2022008016 A MX 2022008016A MX 2022008016 A MX2022008016 A MX 2022008016A MX 2022008016 A MX2022008016 A MX 2022008016A
Authority
MX
Mexico
Prior art keywords
antagonist compound
formula
compound
compounds
prevent
Prior art date
Application number
MX2022008016A
Other languages
English (en)
Inventor
Zhiyong Yu
Pan Li
Yu Zhou
Meng Lv
Beidi Xu
Wei Pang
Qiaodong Wen
Yongqiang Shi
Zhao Sun
Original Assignee
Adlai Nortye Biopharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adlai Nortye Biopharma Co Ltd filed Critical Adlai Nortye Biopharma Co Ltd
Publication of MX2022008016A publication Critical patent/MX2022008016A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Se proporcionan un compuesto de Fórmula (I) y una composición farmacéutica del mismo, así como un método para usar los compuestos de Fórmula (I) para prevenir y/o tratar trastornos relacionados con el sistema inmunitario. (ver Fórmula).
MX2022008016A 2019-12-26 2020-12-22 Compuesto antagonista de pd-l1. MX2022008016A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201911368320 2019-12-26
PCT/CN2020/138157 WO2021129584A1 (zh) 2019-12-26 2020-12-22 Pd-l1拮抗剂化合物

Publications (1)

Publication Number Publication Date
MX2022008016A true MX2022008016A (es) 2022-07-27

Family

ID=76574838

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022008016A MX2022008016A (es) 2019-12-26 2020-12-22 Compuesto antagonista de pd-l1.

Country Status (12)

Country Link
US (1) US20230054028A1 (es)
EP (1) EP4083032A4 (es)
JP (2) JP7611591B2 (es)
KR (1) KR20220121254A (es)
CN (1) CN115066423B (es)
AU (1) AU2020413555B2 (es)
CA (1) CA3160606A1 (es)
IL (1) IL294209A (es)
MX (1) MX2022008016A (es)
SA (1) SA522432781B1 (es)
WO (1) WO2021129584A1 (es)
ZA (1) ZA202206266B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4543876A1 (en) * 2022-06-21 2025-04-30 Chulalongkorn University 1,4-diphenyl-1 h-indazole and 1-pyridin-2-yl-4-phenyl-1 h-indazole derivatives as pd-1/pd-l1 modulators for the treatment of cancer
CN115611700B (zh) * 2022-10-11 2024-06-14 辽宁东大光明化工科技有限责任公司 一种1-溴-2,5-二氯-3-氟苯的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2008282728B2 (en) * 2007-08-02 2012-04-19 Amgen Inc. Pl3 kinase modulators and methods of use
KR102276644B1 (ko) * 2013-09-04 2021-07-13 브리스톨-마이어스 스큅 컴퍼니 면역조절제로서 유용한 화합물
US9850225B2 (en) * 2014-04-14 2017-12-26 Bristol-Myers Squibb Company Compounds useful as immunomodulators
MX2019000123A (es) * 2016-07-08 2019-04-01 Squibb Bristol Myers Co Derivados de 1,3-dihidroxi-fenilo utiles como inmunomoduladores.
JOP20180040A1 (ar) * 2017-04-20 2019-01-30 Gilead Sciences Inc مثبطات pd-1/pd-l1
CN109665968B (zh) * 2017-10-16 2022-02-22 四川科伦博泰生物医药股份有限公司 并环化合物及其制备方法和用途
CN112876411A (zh) * 2019-02-21 2021-06-01 杭州阿诺生物医药科技有限公司 化合物及其在合成pdl1拮抗剂类药物分子中的应用

Also Published As

Publication number Publication date
IL294209A (en) 2022-08-01
KR20220121254A (ko) 2022-08-31
EP4083032A1 (en) 2022-11-02
SA522432781B1 (ar) 2025-05-15
AU2020413555A1 (en) 2022-06-30
JP2024178221A (ja) 2024-12-24
JP7611591B2 (ja) 2025-01-10
CN115066423A (zh) 2022-09-16
AU2020413555B2 (en) 2024-08-01
CN115066423B (zh) 2024-02-02
JP2022552693A (ja) 2022-12-19
CA3160606A1 (en) 2021-07-01
BR112022012737A2 (pt) 2022-09-06
WO2021129584A1 (zh) 2021-07-01
ZA202206266B (en) 2023-11-29
US20230054028A1 (en) 2023-02-23
EP4083032A4 (en) 2023-10-25

Similar Documents

Publication Publication Date Title
DOP2020000102A (es) Compuestos útiles para inhibir a cdk7
NI201900070A (es) Compuestos heterocíclicos como inmunomoduladores
CL2020000886A1 (es) Derivados de 1-benzil-2-imino-4-fenil-5-oxoimidazolidina como inhibidores de la proteasa del vih.
CL2019002204A1 (es) Compuestos inhibidores del vih.
CL2018003701A1 (es) Compuestos heterocíclicos como inmunomoduladores.
NI201700020A (es) Compuestos de aminopirimidinilo como inhibidores de jak
MX2018003432A (es) Compuestos heterociclicos y usos de los mismos.
CO2018007528A2 (es) Compuestos heterocíclicos como inmunomoduladores
CL2015003200A1 (es) Potenciador de inhibidores del homólogo de zeste
CL2018001230A1 (es) Tratamiento de osteoartritis
CR20160564A (es) Dinucleótidos cíclicos como moduladores de sting
MX2019007471A (es) Composiciones y métodos para inhibir la actividad de la arginasa.
CO2018008759A2 (es) Inhibidores de mcl-1 y métodos de uso de los mismos
CO2018000589A2 (es) Oxiesteroles y composiciones farmacéuticas que los contienen
MX380394B (es) Compuesto novedoso de bifenilo o una sal del mismo.
MX381707B (es) Nuevos derivados biciclicos, un proceso para su preparacion y composiciones farmaceuticas que los contienen.
MX376833B (es) Oxiesteroles y metodos de uso de los mismos.
EA201892838A1 (ru) Новые пиперидинильные производные, способ их получения и фармацевтические композиции, содержащие их
UY37182A (es) Derivados de indolina sustituidos como inhibidores de la replicación viral del dengue
EA201692249A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
MX388321B (es) Compuestos de aminopurina sustituida, composiciones del mismo, y metodos de tratamiento con los mismos.
EA201692265A1 (ru) Ингибиторы фосфатидилинозитол-3-киназы
MX2018005045A (es) Inhibidores de factor xia.
MX374383B (es) Derivados de carboxamida como inhibidores de smurf-1
CO2017001389A2 (es) Compuestos de azetidiniloxifenilpirrolidina